PacBio Announces Record Preliminary Fourth Quarter 2021 Revenue, New Sequencing Kits and Workflows, and Expanded Collaborations
January 11, 2022 07:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced unaudited preliminary revenue...
Radboud University Medical Center Increases HiFi Sequencing Capacity with PacBio’s Sequel IIe
January 07, 2022 09:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced Radboud University Medical...
Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems
January 06, 2022 09:00 ET
|
Pacific Biosciences of California, Inc.; Azenta Life Sciences
MENLO PARK, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The...
PacBio and Care4Rare Consortium Collaborate on Rare Disease Research Study
January 05, 2022 09:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- PacBio, a leading provider of high-quality, long-read sequencing platforms, and the Care4Rare Canada Consortium (Care4Rare) announce today they...
PacBio to Present at Upcoming Investor Conference
January 04, 2022 16:05 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that its executives will be speaking virtually at the following investor conference: 40th Annual J.P. Morgan Healthcare...
PacBio’s New HiFiViral Surveillance Kit Performance is Not Impacted by Omicron Mutations, Delivering Complete SARS-CoV-2 Genomes for All Circulating Variants
December 28, 2021 09:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate, long-read sequencing technology, today announced that its new...
PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases
December 07, 2021 09:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, and the UCLA Institute for Precision Health and...
PacBio Grants Equity Incentive Award to New Employee
December 03, 2021 17:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Dec. 03, 2021 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee...
PacBio Names Jason Kang as Vice President and General Manager for Asia-Pacific Region
November 30, 2021 09:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, long-read sequencing platforms, welcomes Jason Kang as Vice President and General...
PacBio Grants Equity Incentive Award to New Employee
November 19, 2021 17:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee...